Melatonin and its biological significance;Melatonina i jej biologiczne znaczenie

Polski Merkuriusz Lekarski

Volumn 17, Issue 101, 2004, Pages 523-527

  Boguszewska, Anna ^a   Pasternak, Kazimierz ^a  

^a Katedra i Zaklad Chemii Ogolnej   (Poland)

Author keywords

Aging process; Antioxidant properties; Free radicals; Melatonin; Pineal gland

Indexed keywords

FREE RADICAL; MELATONIN; OXYGEN RADICAL; SEROTONIN;

AGING; ANTIOXIDANT ACTIVITY; BIOSYNTHESIS; CARDIOVASCULAR SYSTEM; HORMONE RELEASE; HUMAN; IMMUNE SYSTEM; MOOD; PINEAL BODY; REVIEW; SLEEP; SLEEP DISORDER; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

AFFECT; AGING; CIRCADIAN RHYTHM; HUMANS; IMMUNE SYSTEM; MELATONIN; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 10844228930     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Adams J.D., Odunze I.N.: Oxygen free radicals and Parkinson's disease. Free Rad. Biol. Med., 1991, 10, 161-169.
2. Bartsch H. i wsp.: Effect of melatonin and pineal extracts on human ovarian and mammary tumor cells in chemosensitivity assay. Life Sci., 2000, 67, 2953-2960.
3. Beyer C.E., Steketee J.D., Saphier D.: Antioxidant properties of melatonin - an emerging mystery. Biochem. Pharmacol., 1998, 56, 1265-1272.
4. Brown G.M.: Light, melatonin and steep-wake cycle. J. Psych. Neurosci., 1994, 19, 345-353.
5. Bubenik G.A.: Gastrointestinal melatonin: localization, function, and clinical relevance. Dig. Dis. Sci., 2002, 47 (10), 2336-2348.
6. Dai J. i wsp.: Transcriptional repression of ROR? activity in human breast cancer cells by melatonin. Mol. Cell. Endocrinol., 2001, 176, 111-120.
7. Harman D.: Free radical theory of aging. Mutat. Res., 1992, 275, 257-266.
8. Harris M.E. i wsp.: Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid (1-40) peptide in cultured hipocampus neurons. Exp. Neurol., 1995, 131, 193-202.
9. Iacovitti L., Stull N.D., Johnston K.: Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress. Brain Res., 1997, 768 (1-2) 317-326.
10. Karasek M., Lewinski A., Reiter R.J.: Melatonina: znaczenie kliniczne i zastosowanie terapeutyczne. Endokrynol. Pol., 2001, 52 (1), 81-100.
11. Karasek M., Reiter R.J.: Czy szyszynka odgrywa rolȩ w procesie starzenia? Endokrynol. Pol., 1997, 48, 277-284.
12. Karbownik M. i wsp.: Melatonin reduces phenylhydrasine-induced oxidative damage to celluler membranes: evidence for the involvement of iron. Int. J. Biochem. Cell Biol., 2000, 32, 1045-1054.
13. Kayumov L., Zhadanova I.V., Shapiro C.M.: Melatonin, sleep, and circadian rhythmns disorders. Semin. Clin. Neuropsychiatry, 2000, 5 (1), 44-55.
14. Konturek S.J.: Melatonina eliksirem młodości? Gerontol. Pol., 1996, 4, 3, 4-13.
15. Lerner A.B., Case J.D., Heinzelman R.V.: Structure of melatonin. J. Am. Chem. Soc., 1959, 81, 6084.
16. Lissoni P. i wsp.: Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur. J. Cancer, 1999, 35 (12), 1688-1692.
17. Lissoni P. i wsp.: Endocrine and immune effects of melatonin therapy in matestatic cancer patients. Eur. J. Cancer Clin. Oncol., 1989, 25 (5), 789-795.
18. Maestroni G.J.M.: The photoperiod transducer melatonin and the immune-hematopoietic system. J. Photochem. Photobiol. B: Biol., 1998, 43, 186-192.
19. Mahal H.S., Sharma H.S., Mukherjee T.: Antioxidant properties of melatonin: a pulse radiolysis study. Free Radic. Biol. Med., 1999, 26, 5/6, 557-565.
20. Messner M. i wsp.: Presence of melatonin in the human hepatobiliary-gastrointestinal tract. Life Sci., 2001, 69 (5), 543-551.
21. Molik E., Ciuryk S.: Rola melatoniny w regulacji poziomu prolaktyny u owiec. Med. Wet., 2003, 59 (2), 104-106.
22. Popławski P.T., Derlacz R.A.: Jak działa melatonina? Post. Bioch., 2003, 49 (1), 9-17.
23. Reiter R.J.: Functional aspects of the pineal hormone melatonin in combating cell and tissue damage induced by free radicals. Eur. J. Endocrinol., 1996, 134, 412-420.
24. Reiter R.J., Oh O.S., Fujimori O.: Melatonin. Its intracellular and genomic actions. Trends Endocrinol. Metab., 1996, 7, 22.
25. Reiter R.J.: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J., 1995, 9, 526-533.
26. Rozencwaig R., Grad B.R., Ochoa J.: The role of melatonin and serotonin in aging. Med. Hypotheses, 1987, 23, 337-352.
27. Zawilska J.B., Nowak J.Z.: Melatonina: regulacja biosyntezy, rola fizjologiczna i znaczenie terapeutyczne. Farm. Pol., 1997, 53, 3, 99-108.
28. Zawilska J.B.: Melatonin in vertebrate retina: biosynthesis, receptors and functions. Pol. J. Pharmacol. Pharm., 1992, 44, 627-654.
29. Zawilska J.B.: The role of calcium in the regulation of melatonin biosynthesis in the retina. Acta Neurobiol. Exp., 1992, 52, 4, 265-274.
30. Zhdanova I.V., Piotrovskaya V.R.: Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans. Pharmacol. Biochem. Behav., 2000, 67 (1), 131-135.